Capital Fund Management (CFM)
AZN icon

Capital Fund Management (CFM)’s AstraZeneca AZN Stock Holding History

Capital Fund Management (CFM)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.74M Buy
34,150
+24,800
+265% +$4.78M 0.03% 752
2025
Q4 		$1.72M Sell
9,350
-6,150
-40% -$1.08M ﹤0.01% 1777
2025
Q3 		$2.38M Buy
+15,500
New +$2.35M 0.01% 1696
2025
Q2 		– Sell
-13,950
Closed -$2.05M – 2334
2025
Q1 		$2.05M Sell
13,950
-800
-5% -$116K 0.01% 1410
2024
Q4 		$1.93M Buy
14,750
+8,350
+130% +$1.17M ﹤0.01% 1501
2024
Q3 		$997K Buy
+6,400
New +$1.03M ﹤0.01% 1685
2023
Q4 		– Sell
-7,600
Closed -$1.03M – 2099
2023
Q3 		$1.03M Sell
7,600
-1,900
-20% -$260K ﹤0.01% 1631
2023
Q2 		$1.36M Sell
9,500
-9,900
-51% -$1.46M 0.01% 1309
2023
Q1 		$2.69M Sell
19,400
-9,350
-33% -$1.26M 0.01% 963
2022
Q4 		$3.9M Sell
28,750
-2,800
-9% -$351K 0.03% 707
2022
Q3 		$3.46M Sell
31,550
-2,850
-8% -$362K 0.03% 674
2022
Q2 		$4.55M Buy
+34,400
New +$4.51M 0.04% 537
2020
Q1 		– Sell
-2,900
Closed -$289K – 1553
2019
Q4 		$289K Buy
+2,900
New +$273K ﹤0.01% 1613
2015
Q1 		– Sell
-11,900
Closed -$838K – 1427
2014
Q4 		$838K Sell
11,900
-5,100
-30% -$365K 0.01% 945
2014
Q3 		$1.21M Sell
17,000
-28,800
-63% -$2.11M 0.01% 857
2014
Q2 		$3.4M Buy
45,800
+500
+1% +$36.1K 0.04% 544
2014
Q1 		$2.94M Buy
45,300
+15,200
+50% +$982K 0.04% 530
2013
Q4 		$1.79M Buy
30,100
+12,700
+73% +$690K 0.02% 740
2013
Q3 		$904K Buy
+17,400
New +$874K 0.01% 919

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Capital Fund Management (CFM)'s AZN Position: Q1 2026 in Review

Capital Fund Management (CFM) opened a new position in AstraZeneca (AZN) in Q1 2026: 51,161 shares worth $10.1M. The stake represents 0.05% of the portfolio and ranks #552 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in AZN as recently as Q2 2025.

Capital Fund Management (CFM) first reported a position in AZN in Q2 2013 and has held it in 22 quarters since. The position peaked at $40.3M in Q4 2023. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Capital Fund Management (CFM) held 51,161 shares of AstraZeneca worth $10.1M as of Q1 2026.
  • AstraZeneca was a new Capital Fund Management (CFM) position in Q1 2026.
  • AstraZeneca made up 0.05% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #552 holding.
  • Capital Fund Management (CFM) first reported a position in AstraZeneca in Q2 2013 and has held it in 22 quarters since.
  • Capital Fund Management (CFM)'s AstraZeneca position peaked at $40.3M in Q4 2023.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.